Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy.

immune checkpoint inhibitor immune-mediated necrotizing myopathy myasthenia gravis myopathy myositis necrotizing autoimmune myopathy

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2020
Historique:
received: 02 07 2020
revised: 16 09 2020
accepted: 22 09 2020
entrez: 11 12 2020
pubmed: 12 12 2020
medline: 12 12 2020
Statut: epublish

Résumé

Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment. Alongside their many advantages, they elicit immune-related adverse events, including myopathy, which potentially result in substantial morbidity if not recognized and treated promptly. Current knowledge of immune checkpoint inhibitor-associated myopathy is limited. We conducted a 5-year retrospective study of patients with immune checkpoint inhibitor-associated myopathy. Clinical features, survival and ancillary test findings were analysed and compared with those of immune-mediated necrotizing myopathy patients without immune checkpoint inhibitor exposure seen during the same time period. We identified 24 patients with immune checkpoint inhibitor-associated myopathy (median age 69 years; range 28-86) and 38 patients with immune-mediated necrotizing myopathy. Ocular involvement occurred in 9/24 patients with immune checkpoint inhibitor exposure, without electrodiagnostic evidence of neuromuscular transmission defect, and in none of the immune-mediated necrotizing myopathy patients (

Identifiants

pubmed: 33305263
doi: 10.1093/braincomms/fcaa181
pii: fcaa181
pmc: PMC7713997
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcaa181

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 04;2(4):e124
pubmed: 26090508
J Immunother Cancer. 2016 Jun 21;4:36
pubmed: 27330809
Neuropathol Appl Neurobiol. 2017 Feb;43(1):62-81
pubmed: 28075491
J Clin Oncol. 2018 Jun 10;36(17):1714-1768
pubmed: 29442540
Neurology. 2019 Sep 10;93(11):e1093-e1103
pubmed: 31405908
Curr Neurol Neurosci Rep. 2018 Aug 4;18(10):63
pubmed: 30078154
J Immunother Cancer. 2017 Nov 21;5(1):95
pubmed: 29162153
JAMA Neurol. 2017 Oct 1;74(10):1216-1222
pubmed: 28873125
Neurology. 2018 Feb 6;90(6):e507-e517
pubmed: 29330311
J Immunother. 2018 May;41(4):208-211
pubmed: 29200081
Stroke. 2007 Mar;38(3):1091-6
pubmed: 17272767
J Rheumatol. 2001 Oct;28(10):2366-7
pubmed: 11669187
J Thorac Oncol. 2017 Jul;12(7):e90-e91
pubmed: 28629544
Muscle Nerve. 2013 Apr;47(4):585-7
pubmed: 23463255
JAMA Neurol. 2015 Sep;72(9):996-1003
pubmed: 26192196
J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):904-8
pubmed: 19240048
Neurology. 2019 Jul 23;93(4):183-184
pubmed: 31332091
J Immunol Res. 2014;2014:405956
pubmed: 24741598
Am J Ophthalmol. 2019 Jun;202:109-117
pubmed: 30772350
J Neurol. 2012 Sep;259(9):1982-4
pubmed: 22527235
J Neuroimmunol. 2019 Jul 15;332:69-72
pubmed: 30959340
J Autoimmun. 2019 Jun;100:105-113
pubmed: 30862448
Circulation. 2018 Aug 14;138(7):743-745
pubmed: 30359135
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
Muscle Nerve. 2017 Nov;56(5):881-886
pubmed: 28181274
Neuromuscul Disord. 2018 Jan;28(1):87-99
pubmed: 29221629
Ophthalmic Plast Reconstr Surg. 2020 Mar/Apr;36(2):109-117
pubmed: 31261163
Neuromuscul Disord. 2017 Mar;27(3):266-268
pubmed: 28109638
Mayo Clin Proc. 2017 May;92(5):826-837
pubmed: 28473041
Muscle Nerve. 2019 May;59(5):544-548
pubmed: 30488463
J Clin Rheumatol. 2014 Jan;20(1):47-8
pubmed: 24356484
J Neurooncol. 2018 May;137(3):601-609
pubmed: 29332184
Neurology. 2018 Sep 4;91(10):e985-e994
pubmed: 30089619
Muscle Nerve. 2016 Sep;54(3):507-9
pubmed: 27287688
J Immunother. 2017 Apr;40(3):114-116
pubmed: 28234667
Ann Rheum Dis. 2019 Jan;78(1):150-152
pubmed: 30185415
Muscle Nerve. 2019 Jul;60(1):E8-E9
pubmed: 31050017
J Clin Invest. 2018 Feb 1;128(2):715-720
pubmed: 29309048
Ann Rheum Dis. 2019 Nov;78(11):e129
pubmed: 30242031
Medicine (Baltimore). 2014 May;93(3):150-7
pubmed: 24797170
Clin Neurophysiol. 2019 Aug;130(8):1417-1439
pubmed: 31080019
Neurology. 2017 Sep 12;89(11):1127-1134
pubmed: 28821685
Muscle Nerve. 2015 Aug;52(2):307-8
pubmed: 25759003
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Science. 1996 Mar 22;271(5256):1734-6
pubmed: 8596936

Auteurs

Shahar Shelly (S)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

James D Triplett (JD)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Marcus V Pinto (MV)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Margherita Milone (M)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Felix E Diehn (FE)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Anastasia Zekeridou (A)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Teerin Liewluck (T)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Classifications MeSH